×
About 3,253 results

ALLMedicine™ Pediatric Dermatology Center

Research & Reviews  723 results

Dermatology Drugs for Children-U.S. Food and Drug Administration Perspective.
https://doi.org/10.1016/j.det.2022.02.004
Dermatologic Clinics; Epps RE

Jun 25th, 2022 - Drug development regulation needs of the pediatric population were not addressed until later in the twentieth century. Because of legislation including the Best Pharmaceuticals for Children Act (BPCA) and Pediatric Research Equity Act (PREA), clin...

Hair disorder treatments are evolving
https://www.mdedge.com/dermatology/article/255473/hair-nails/hair-disorder-treatments-are-evolving
Kathleen Doheny

Jun 15th, 2022 - “No matter who the patient is, whether a child, adolescent, or adult, the key to figuring out hair disease is getting a good history,” Maria Hordinsky, MD, professor and chair of the department of dermatology at the University of Minnesota, Minnea.

Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
https://clinicaltrials.gov/ct2/show/NCT04113187

Jun 14th, 2022 - Hereditary Hemorrhagic Telangiectasia (HHT) is a rare systemic autosomal dominantly inherited disorder of angiogenesis. Its major feature is the occurrence in 90% of patients of spontaneous and recurrent epistaxis responsible for iron deficiency a...

Atopic dermatitis: Options abound, and more are coming
https://www.mdedge.com/dermatology/article/255353/atopic-dermatitis/atopic-dermatitis-options-abound-and-more-are-coming
Kathleen Doheny

Jun 10th, 2022 - For dermatologists and others treating patients with atopic dermatitis (AD), it is “an incredible time,” Lawrence F. Eichenfield, MD, said at MedscapeLive’s Women’s & Pediatric Dermatology Seminar.

Biologics, Women, and Pregnancy: What’s Known?
https://www.mdedge.com/dermatology/article/255335/psoriasis/biologics-women-and-pregnancy-whats-known
Kathleen Doheny

Jun 8th, 2022 - As the use of biologics for dermatologic conditions has increased, so have questions from patients about their safety during pregnancy and lactation, their effects on fertility, and potential effects on the developing fetus and the child’s develop.

see more →

Guidelines  1 results

Consensus Communication on Early Peanut Introduction and Prevention of Peanut Allergy i...
https://doi.org/10.1111/pde.12685
Pediatric Dermatology; Fleischer DM, Sicherer S et. al.

Sep 12th, 2015 - The purpose of this brief communication is to highlight emerging evidence regarding potential benefits of supporting early rather than delayed peanut introduction during the period of complementary food introduction in infants. This document shoul...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  15 results

Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
https://clinicaltrials.gov/ct2/show/NCT04113187

Jun 14th, 2022 - Hereditary Hemorrhagic Telangiectasia (HHT) is a rare systemic autosomal dominantly inherited disorder of angiogenesis. Its major feature is the occurrence in 90% of patients of spontaneous and recurrent epistaxis responsible for iron deficiency a...

Tencel vs. Standard Cotton Therapeutic Garments as an Adjunct Treatment for Moderate to Severe Atopic Dermatitis in Children
https://clinicaltrials.gov/ct2/show/NCT03843437

Sep 10th, 2021 - Atopic dermatitis (eczema) is a chronically recurrent, pruritic disorder most common in infants and young children. It is one of the most common pediatric dermatologic disorders, affecting 15-20% of all children between 6 months and 10 years of ag...

Characterize Metzker Pigmentary Disorders
https://clinicaltrials.gov/ct2/show/NCT04966533

Jul 19th, 2021 - Metzker pigmentary disorders are frequent cause of consultation in pediatric dermatology. The investigators can describe 4 patterns. They must be differentiated from mosaicisms because they aren't associated with neurologic disorders and don't req...

Efficacy Of Antenatal Maternal Supplementation With GOS/Inulin Prebiotics On Atopic Dermatitis Prevalence In High-Risk One-Year-Old Children
https://clinicaltrials.gov/ct2/show/NCT03183440

Jun 16th, 2021 - Study design : Inclusion visit at 20 weeks of gestation : randomization start of supplementation (GOS/inulin or placebo) Phone call at 24 weeks of gestation : checking tolerance checking observance 32 weeks of gestation visit : replenishment of pr...

Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations
https://clinicaltrials.gov/ct2/show/NCT02761473

Aug 20th, 2020 - Urticaria pigmentosa (UP) is a relatively common disorder in pediatric patients, and little is known regarding the somatic and germline genetic variants associated with the disease. The University of Minnesota Masonic Children's Hospital is a regi...

see more →

News  559 results

Hair disorder treatments are evolving
https://www.mdedge.com/dermatology/article/255473/hair-nails/hair-disorder-treatments-are-evolving
Kathleen Doheny

Jun 15th, 2022 - “No matter who the patient is, whether a child, adolescent, or adult, the key to figuring out hair disease is getting a good history,” Maria Hordinsky, MD, professor and chair of the department of dermatology at the University of Minnesota, Minnea.

Atopic dermatitis: Options abound, and more are coming
https://www.mdedge.com/dermatology/article/255353/atopic-dermatitis/atopic-dermatitis-options-abound-and-more-are-coming
Kathleen Doheny

Jun 10th, 2022 - For dermatologists and others treating patients with atopic dermatitis (AD), it is “an incredible time,” Lawrence F. Eichenfield, MD, said at MedscapeLive’s Women’s & Pediatric Dermatology Seminar.

Biologics, Women, and Pregnancy: What’s Known?
https://www.mdedge.com/dermatology/article/255335/psoriasis/biologics-women-and-pregnancy-whats-known
Kathleen Doheny

Jun 8th, 2022 - As the use of biologics for dermatologic conditions has increased, so have questions from patients about their safety during pregnancy and lactation, their effects on fertility, and potential effects on the developing fetus and the child’s develop.

Steroid phobia drives weaker prescribing, nonadherence for AD
https://www.mdedge.com/dermatology/article/254451/atopic-dermatitis/steroid-phobia-drives-weaker-prescribing-nonadherence
Jeff Craven

May 9th, 2022 - Concerns about the side effects of topical corticosteroids continue to be a source of anxiety for parents of children with atopic dermatitis (AD), leading some medical providers to prescribe weaker products, Nanette B. Silverberg, MD, said at the.

Derms in survey say climate change is impacting their patients
https://www.mdedge.com/dermatology/article/251759/mixed-topics/derms-survey-say-climate-change-impacting-their-patients
Christine Kilgore

Feb 14th, 2022 - Global climate change is hitting home for dermatologists, according to a recent survey in which the majority of participants said their patients are already being impacted. Almost 80% of the 148 participants who responded to an electronic survey r.

see more →